-
Study aim
-
The aim of current study is to survey effects of adding trinitroglycerin (TNG) to the patient controlled intravenous analgesia pump in patients with lower limb orthopedic surgery
-
Design
-
Clinical trial study, with parallel groups, double blinded, randomized
-
Settings and conduct
-
75 patients who undergo surgery due to fracture of the lower limbs in Rasul Akram hospital were selected and were randomly per muted blocks and based on online randomization software, divided into three equal groups and received one of following analgesia methods via intravenous pain pump after the end of surgery in recovery:
Control group: Without using Trinitriglycerin (TNG).
First intervention group: Using 500 microgram (mcg) Trinitriglycerin (TNG) in the pain pump.
Second intervention group: Using 1000 mcg, TNG in the pain pump.
Pain in patients is measured 4, 8, 12 and 24 hours after surgery by Visual analogue scale.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Lower extremities orthopedic patients, Spinal anesthesia with 15 milligram (mg) bupivacain 0.5%, Patients with American Society of Anesthesiologists (ASA) I,II.
Exclusion criteria:
Addiction to alcohol, benzodiazepines and opium, Heart failure, Patients dissatisfaction, Allergies to any of used drugs, Seizure, Valvular heart disease,
Arrhythmia.
-
Intervention groups
-
First intervention group: Using 500 microgram (mcg) Trinitriglycerin (TNG) in the pain pump. (Nitral, Caspian Tamin Pharmaceutical Co.)
Second intervention group: Using 1000 mcg, TNG in the pain pump.
Control group: Pain pump without using TNG in the pain pump
-
Main outcome variables
-
Patient's pain 4, 8, 12 and 24 hours after surgery.